Literature DB >> 19605583

Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.

Vicki L Greengrass1, Megan M Plate, Pauline M Steele, Justin T Denholm, Catherine L Cherry, Lisa M Morris, Anna Hearps, Suzanne M Crowe.   

Abstract

We evaluated the new low-cost ExaVir Load (version 3) reverse transcriptase viral load assay against the Roche Cobas Amplicor assay. Results for samples tested using the reverse transcriptase assay correlated well with those obtained with the Roche assay (r = 0.85; n = 202). The version 3 reverse transcriptase assay shows improved sensitivity compared to the previous version.

Entities:  

Mesh：

Year:  2009        PMID： 19605583      PMCID： PMC2738117          DOI： 10.1128/JCM.00805-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring.

Authors:  Vicki L Greengrass; Shannon P Turnbull; Jane Hocking; Amanda L Dunne; Gilda Tachedjian; Gary E Corrigan; Suzanne M Crowe
Journal:  Curr HIV Res       Date:  2005-04       Impact factor: 1.581

2.  Comparative evaluation of the VERSANT HIV-1 RNA 1.0 kinetic PCR molecular system (kPCR) for the quantification of HIV-1 plasma viral load.

Authors:  Jean Ruelle; Karima Jnaoui; Isabelle Lefèvre; Najet Lamarti; Patrick Goubau
Journal:  J Clin Virol       Date:  2009-02-18       Impact factor: 3.168

3.  COBAS AMPLICOR: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR.

Authors:  N DiDomenico; H Link; R Knobel; T Caratsch; W Weschler; Z G Loewy; M Rosenstraus
Journal:  Clin Chem       Date:  1996-12       Impact factor: 8.327

4.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

5.  Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.

Authors:  W A O'Brien; P M Hartigan; E S Daar; M S Simberkoff; J D Hamilton
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

6.  Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.

Authors:  M D Hughes; V A Johnson; M S Hirsch; J W Bremer; T Elbeik; A Erice; D R Kuritzkes; W A Scott; S A Spector; N Basgoz; M A Fischl; R T D'Aquila
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

7.  Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings.

Authors:  Sumathi Sivapalasingam; Shaffiq Essajee; Phillipe N Nyambi; Vincenza Itri; Bruce Hanna; Robert Holzman; Fred Valentine
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

8.  Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay.

Authors:  Cheryl Jennings; Susan A Fiscus; Suzanne M Crowe; Aleksandra D Danilovic; Ralph J Morack; Salvatore Scianna; Ada Cachafeiro; Donald J Brambilla; Jorg Schupbach; Wendy Stevens; Richard Respess; Oliviero E Varnier; Gary E Corrigan; J Simon Gronowitz; Michael A Ussery; James W Bremer
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

9.  Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma.

Authors:  Anders Malmsten; Xing-Wu Shao; Staffan Sjödahl; Eva-Lena Fredriksson; Ingvar Pettersson; Thomas Leitner; Clas F R Källander; Eric Sandström; J Simon Gronowitz
Journal:  J Med Virol       Date:  2005-07       Impact factor: 2.327

10.  Monitoring of human immunodeficiency virus infection in resource-constrained countries.

Authors:  Suzanne Crowe; Shannon Turnbull; Robert Oelrichs; Amanda Dunne
Journal:  Clin Infect Dis       Date:  2003-07-01       Impact factor: 9.079
View more
  12 in total

1.  Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.

Authors:  Paul Stewart; Ada Cachafeiro; Sonia Napravnik; Joseph J Eron; Ian Frank; Charles van der Horst; Ronald J Bosch; Daniel Bettendorf; Peter Bohlin; Susan A Fiscus
Journal:  J Clin Virol       Date:  2010-09-15       Impact factor: 3.168

2.  Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.

Authors:  Pedro Borrego; Maria Fátima Gonçalves; Perpétua Gomes; Lavínia Araújo; Inês Moranguinho; Inês Brito Figueiredo; Isabel Barahona; José Rocha; Claudino Mendonça; Maria Cesarina Cruz; Jorge Barreto; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2017-05-17       Impact factor: 5.948

Review 3.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

4.  Low-cost tools for diagnosing and monitoring HIV infection in low-resource settings.

Authors:  Grace Wu; Muhammad H Zaman
Journal:  Bull World Health Organ       Date:  2012-10-19       Impact factor: 9.408

5.  HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays.

Authors:  Sonia Napravnik; Ada Cachafeiro; Paul Stewart; Joseph J Eron; Susan A Fiscus
Journal:  J Clin Virol       Date:  2009-11-05       Impact factor: 3.168

Review 6.  Low-cost assays for monitoring HIV infected individuals in resource-limited settings.

Authors:  Pachamuthu Balakrishnan; Hussain Syed Iqbal; Saravanan Shanmugham; Janardhanan Mohanakrishnan; Sunil S Solomon; Kenneth H Mayer; Suniti Solomon
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

7.  Performance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, Zimbabwe.

Authors:  Pascale Ondoa; Tinei Shamu; Michelle Bronze; Maureen Wellington; Tamara Sonia Boender; Corry Manting; Kim Steegen; Rudi Luethy; Tobias Rinke de Wit
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

8.  Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea.

Authors:  Janet Gare; Angela Kelly-Hanku; Claire E Ryan; Matthew David; Petronia Kaima; Ulato Imara; Namarola Lote; Suzanne M Crowe; Anna C Hearps
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

Review 9.  Systematic review of the performance of HIV viral load technologies on plasma samples.

Authors:  Kimberly A Sollis; Pieter W Smit; Susan Fiscus; Nathan Ford; Marco Vitoria; Shaffiq Essajee; David Barnett; Ben Cheng; Suzanne M Crowe; Thomas Denny; Alan Landay; Wendy Stevens; Vincent Habiyambere; Jos Perrins; Rosanna W Peeling
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

Review 10.  Point of Care Technologies for HIV.

Authors:  Mohan Kumar Haleyur Giri Setty; Indira K Hewlett
Journal:  AIDS Res Treat       Date:  2014-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.